Archives

by in
Entry Author Date Location
Tetra Discovery Lands Funding, Plans Alzheimer’s Drug Trial in 2015 10/31/14 Detroit
East Coast Biotech Roundup: GliaCure, Civitas, T2, & More 09/29/14 Boston
Blessed By Angels, GliaCure Tests New Alzheimer’s Approach In Humans 09/26/14 Boston
To Solve Alzheimer’s Mystery, Better Biological Clues Sorely Needed 07/29/14 National
West Coast Biotech Roundup: Genentech, CareDx, and More 07/17/14 San Diego
Who Needs Biotech VCs, Anyway? 07/15/14 San Francisco
Seeking Tau: BMS Buys iPierian and Brain-Disease Program for $175M 04/29/14 San Francisco
Washington Lawmakers Ax Life Sciences Fund, Tech Incentives 03/27/14 Seattle
San Diego Life Sciences Roundup: Acadia, Ignyta, Tracon, & More 03/07/14 San Diego
Edison Shedding Light on Energy Production in Diseased Cells 03/06/14 San Francisco
Biogen, Eisai Join Up in Alzheimer’s Drug Pact 03/05/14 Boston
East Coast Biotech Roundup: Enanta, NY Disruptors, Repligen, & More 01/24/14 Boston
Tillman Gerngross, the Scientist Turned Scientific Businessman 01/09/14 Boston
East Coast Biotech Roundup: Moderna, Aileron, Seres, & More 11/22/13 Boston
J&J Joins With Evotec to Hunt for Early Causes of Alzheimer’s Disease 11/13/13 San Francisco
Alector Goes After Alzheimer’s, With Cash from Polaris & OrbiMed 10/31/13 San Francisco
Atlas Startup, Rodin, Hopes to Rewire Neurons to Improve Memory 08/12/13 Boston
Prothena of South San Francisco Gets Head Start as Elan Spinoff 01/09/13 San Francisco
Forest Labs, Adamas in Pact to Develop Alzheimer’s Drug Combo 11/15/12 New York
Translating Nobel Science Into Novel Drugs 10/12/12 San Francisco
EnVivo Forges Ahead With Alzheimer’s Drug 08/23/12 Boston
Alzheimer’s R&D Isn’t Doomed, it’s Learning From Failure 08/20/12 National
SD Life Sciences Roundup: Illumina, Sophiris Bio, & New Funding Deals 04/05/12 San Diego
SavingStar, Exinda, & NeuroPhage: A Trio of Boston Startup Deals 03/08/12 Boston
Satori Cultivates Prolific Herb for Promising Alzheimer’s Weapon 02/28/12 Boston
Satori Snaps Up $15M for Alzheimer’s Drugs 02/23/12 Boston
Xconomy Storms NYC: Top Ten Topics in the Big Apple in 2011 12/27/11 New York
EnVivo Posts Positive Trial of Schizophrenia Drug 12/05/11 Boston
Eli Lilly CEO John Lechleiter on Tackling the Pharmaceutical R&D Crisis (Part 2) 11/22/11 National
Merck Unveils Alzheimer’s and Diabetes Projects, Personnel Changes 11/10/11 New York
Page 1 of 2 next page »